<DOC>
	<DOC>NCT00154258</DOC>
	<brief_summary>Clozapine is an antipsychotic. This open study will evaluate the safety and efficacy of long term treatment of clozapine in patients with treatment-resistant schizophrenia.</brief_summary>
	<brief_title>A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia</brief_title>
	<detailed_description>Clozapine is an antipsychotic. This open study will evaluate the safety and efficacy of long term treatment of clozapine in patients with treatment-resistant schizophrenia.</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<criteria>Attended the previous Phase IIb (core) study Improved during the core study No safety issues during the core study Discontinued the core study Pregnant or nursing (lactating) women Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Schizophrenia, treatment-resistant, clozapine</keyword>
</DOC>